Alveolus is a leader in the emerging field of non-vascular interventional stenting through next generation stent technology.

Alveolus is designing, manufacturing, and testing their Hybrid Stent Technology System and other advanced devices for the battle against cancerous and benign obstructive lumen disease.

Alveolus has partnered itself with business leaders, thought-leading physicians, and internationally recognized medical institutions in order to build value and quality in the creation of curative and palliative treatment alternatives.